Tuberculosis remains world’s deadliest infectious disease despite being preventable and curable. Around 1.23 million of 10.7 ...

India's Serum Institute of India (SII) has announced that it will manufacture an experimental tuberculosis (TB) vaccine under ...

The Gates Medical Research Institute (Gates MRI) has signed an agreement with Pune-based Serum Institute of India Private ...

Serum Institute of India has partnered with Gates Medical Research Institute to manufacture M72/AS01E, a tuberculosis vaccine ...

Serum Institute will invest over US$100 million to manufacture the M72/AS01E vaccine if approved, a breakthrough that could become the world's first new tuberculosis vaccine in more than a century. In ...

A new TB vaccine could be the biggest breakthrough in over 100 years. The Serum Institute of India (SII) will manufacture the ...

The University of Oxford and the Serum Institute of India (SII) have started the world's first human trial of a vaccine ...

Gates MRI and Serum Institute partner to manufacture a novel TB vaccine, investing $100 million for scalable production.

The Gates Medical Research Institute and Serum Institute of India have signed an agreement to mass-produce the M72/AS01E ...

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on. Benchmark your ...

Watch videos, top stories and articles on Serum Institute Of India (sii) at moneycontrol.com.